Detalhe da pesquisa
1.
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119.
J Pathol Clin Res
; 10(3): e12371, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627977
2.
Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDx.
Appl Immunohistochem Mol Morphol
; 29(9): 667-673, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973887